Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
Palau Pharma has developed a small molecule H4 receptor antagonist that is about to enter Phase I clinical trials for the treatment of allergic rhinitis and asthma. More
Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More
The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
1217B is a botanically derived potential drug candidate that inhibits the synthesis of several key pro-inflammatory mediators involved in the pathophysiology of allergic asthma and has been found to improve lung functionality in a mouse model. More
No in vivo data- New multifunctional steroid compound used for treating e.g. asthma, Alzheimer disease and psoriasis comprises steroid component, superoxide dismutase mimic component and optionally nitogen oxide donor component. The present... More
A new composition of matter comprising microparticles with both oxidized cellulose and glucans. The composition includes pharmaceutically acceptable carrier and as an active ingredient oxidized cellulose. Preferable the oxidized cellulose should be... More
Displaying 1..10 of 27 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
